Nootropics
Noopept
A synthetic cognition-research compound with laboratory and animal findings that should not be mistaken for established healthy-human benefit.
Research explained · evidence varies by outcome
Also known as: omberacetam · N-phenylacetyl-L-prolylglycine ethyl ester
Practical use
Applying the explained evidence
- Where it fits
- A synthetic cognition-research compound with laboratory and animal findings that should not be mistaken for established healthy-human benefit.
- Put the information into practice
- Noopept-only results should be separated from multi-ingredient experiments. An intervention containing Noopept and another biologically active compound cannot show what Noopept alone would do.
- Make the claim measurable
- Specify the claimed effect: alertness, memory, attention or another outcome. Check whether researchers measured that outcome directly; a mechanism or a subjective feeling is a different kind of evidence.
- Keep this limit in view
- A transcription-factor response in cells is not a human memory outcome or evidence of a safe way to improve oxygen adaptation.
Overview
Noopept is the common name for N-phenylacetyl-L-prolylglycine ethyl ester. The studies summarized here investigate cellular stress signaling and experimental disease models. The label “cognitive enhancer” describes a research or marketing category; it is not a guarantee of improved concentration or learning in a healthy person.
Risks and limitations
The cited mechanistic experiments do not provide a dependable human long-term safety or interaction profile. A market-surveillance study found unauthorized nootropics in commercial products; a package label is not sufficient evidence of identity, dose or regulatory compliance.
How to read this
Noopept-only results should be separated from multi-ingredient experiments. An intervention containing Noopept and another biologically active compound cannot show what Noopept alone would do.
Research explained
Cellular HIF-1 signaling
Who was studied
Cultured SH-SH5Y cells and laboratory reporter methods.
What was found
Noopept increased HIF-1 DNA-binding activity and affected signaling associated with stabilization of HIF1α.
What it cannot establish
A transcription-factor response in cells is not a human memory outcome or evidence of a safe way to improve oxygen adaptation.
Read the original studyA combination in a Parkinson-like rat model
Who was studied
PINK1-knockout rats treated with a formulation containing forskolin and Noopept.
What was found
The researchers reported improvements in motor and neural outcomes with the combination.
What it cannot establish
The model is preclinical and the formulation has multiple components. Results cannot establish Noopept-alone efficacy or a human disease-modifying treatment.
Read the original studyMarket surveillance of nootropic products
Who was studied
12 official medicines-control laboratories collected data on 159 samples during 2020–2024.
What was found
The study identified multiple unauthorized compounds, including Noopept, in the examined market samples.
What it cannot establish
The sample collection was not a random survey of every product; it establishes a product-quality/regulatory concern, not a failure rate for the entire market.
Read the original studyResearch integrity belongs beside benefit claims
A 2021 Noopept inflammation paper has a published retraction notice. It should not be cited as reliable confirmation of a benefit. A reader following a secondary article should check whether its reference still has a valid publication status.
Supporting sourceWhat would establish a practical benefit
For a healthy-person cognition claim, a relevant study would need suitable participants, blinding and a control condition, prespecified cognitive outcomes, enough follow-up and adverse-event reporting. A positive cell result is an earlier research step, not a substitute.
Half-life and subjective duration
How long someone feels an effect is not the same as a measured pharmacokinetic half-life. The primary studies summarized here do not establish a validated dosing interval for healthy consumers.
Common questions
Does the combination rat study isolate Noopept’s effect?
No. The mixture contains another active compound, and the findings belong to that tested formulation.
Does a mechanistic result tell me how much to take?
No. A concentration used in cells does not define a safe human exposure.
Sources
Retraction notice for a Noopept inflammation paper
A combination in a Parkinson-like rat model
Market surveillance of nootropic products
Sources checked 2026-09-28.
General education; not a personal treatment plan.